DelMar Pharmaceuticals Announces Issuance of New Patent on First-in-Class DNA-targeting Agent, VAL-083 Sep 20, 2017
First Global Provides Update on Litigation and Files Fresh As Amended Statement of Claim Against Sep 18, 2017
DelMar Pharmaceuticals Receives IND Allowance from FDA to Initiate Clinical Trials of VAL-083 for the Treatment of Ovarian Cancer Sep 18, 2017
Manitok Energy Inc. and Questfire Energy Corp. Announce an Extension to the Outside Date to Complete the Arrangement Sep 17, 2017
Hemisphere Energy Announces Strategic Debt Refinancing to Accelerate Growth and Development of its Southern Alberta Oil Assets Sep 17, 2017
Triumph Gold Announces Completion of its 2017 Field Campaign and Discovery of the Tinta Hill Vein Structure up to 1.17 Km to the NW of its Previous Known Extent Sep 14, 2017
Manganese X Energy Enters Into Confidentiality Agreement with the University of Minnesota to Develop Value Added Products Sep 14, 2017
RedHill Biopharma Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S. Sep 14, 2017
